FDA Inspection
VitalantVitalant – FDA Inspection, Sep 12, 2014
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on September 12, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- September 12, 2014
- Product Type
- Biologics
View Company Profile
ID · 1251444f-4c62-4139-9739-a79907aba556
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 895712
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 9, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 18, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 18, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 22, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 4, 2009 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1214538 - 2023-08-09
- FDA Inspection 1098166 - 2019-07-18
- FDA Inspection 984109 - 2016-08-18
- FDA Inspection 789482 - 2012-06-22
- FDA Inspection 604009 - 2009-08-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.